Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on Hemodialysis

BACKGROUND/AIMS: We evaluated the efficacy and safety of daclatasvir (DCV) and asunaprevir (ASV) in patients with chronic hepatitis C virus (HCV) infection on hemodialysis. METHODS: We performed a single-arm, multicenter prospective study. Twenty-one chronic hemodialysis patients with HCV infection...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut Liver
Autors principals: Lee, Byung Seok, Song, Myeong Jun, Kwon, Jung Hyun, Lee, Tae Hee, Jang, Ji Woong, Kim, Seok Hyun, Lee, Sae Hwan, Kim, Hong Soo, Kim, Ji Hoon, Kim, Seok Bae, Ko, Soon Young, Song, Do Seon
Format: Artigo
Idioma:Inglês
Publicat: Editorial Office of Gut and Liver 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430432/
https://ncbi.nlm.nih.gov/pubmed/30400729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18240
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars